Patent details

Basic Information

Publication number:

EP3912979

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP211696315

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TYROSINE KINASE INHIBITORS

French Title of Invention:

INHIBITEURS DE KINASE DE TYROSINE

German Title of Invention:

TYROSIN-KINASE-INHIBITOREN

SPC Number:

Dates

Filing date:

02/06/2016

Grant date:

25/03/2026

EP Publication Date:

24/11/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/03/2026

EP B1 Publication Date:

25/03/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

02/06/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/03/2026

 

 

Name:

Principia Biopharma Inc.

Address:

100 Morris St., Morristown, NJ 07960, United States (US)

Inventor

1

Name:

OWENS, Timothy D.

Address:

United States (US)

2

Name:

GOLDSTEIN, David

Address:

United States (US)

Priority

1

Priority Number:

201562170547 P

Priority Date:

03/06/2015

Priority Country:

United States (US)

2

Priority Number:

201562271689 P

Priority Date:

28/12/2015

Priority Country:

United States (US)

Classification

IPC classification:

C07D 471/04; C07D 473/34; A61K 31/437; A61K 31/52; A61P 35/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202613

Publication date:

25/03/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages